申请人:Niestroj Johannes Andre
公开号:US20060229357A1
公开(公告)日:2006-10-12
The present invention relates to novel inhibitors of prolyl endopeptidase of formula (1)
wherein I, A, X, Y and Z are specified in the description. The compounds are useful for the treatment of diseases such as mild cognitive impairment (MCI), Alzheimer's disease, Down Syndrome, Parkinson disease and Chorea Huntington.
本发明涉及一种新型的脯氨酰内切酶抑制剂,其化学式为(1),其中I、A、X、Y和Z在说明书中有所规定。这些化合物可用于治疗轻度认知障碍(MCI)、阿尔茨海默病、唐氏综合症、帕金森病和亨廷顿舞蹈症等疾病。